Health Catalyst Inc (HCAT) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

HCAT ranks #3991 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

HCAT is a top-conviction position for CDC Financial, Inc. — at 5.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in HCAT belongs to First Light Asset Management, LLC, but the position matters far more to CDC Financial, Inc., who has 5.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Palogic Value Management, L.P. has added to its HCAT position for two straight quarters, increasing it by $6.8M to reach $9.8M today.

BlackRock has trimmed its HCAT position for two straight quarters, cutting it by $8.8M while still holding $3.7M.

HCAT reported a net loss of $264.8M over the trailing twelve months.

• Not yet profitable — net loss of $264.8M over the trailing twelve months
• Revenue declined 7.5% year over year
• Net income declined year over year, from -$100.1M to -$264.8M
• Generated $731.0K in positive operating cash flow
• Current ratio of 1.89x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.05x equity — within a conventional range